Assistant Professor, Department of Pathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
|2014||Texas A&M Health Science Center, College Station, TX, USA, MD, Medicine|
|2010||Abilene Christian University, Abilene, TX, USA, BS, Biology|
|2018-2019||Clinical Fellowship, Gynecological Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX|
|2014-2018||Clinical Residency, Anatomic and Clinical Pathology, Baylor College of Medicine, Houston, TX|
|2018||American Board of Pathology|
Co-Director, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
- Lawson BC, Euscher ED, Bassett RL, Liu J, Ramalingam P, Zhong Y, Fleming ND, Malpica A. A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant?. Am J Surg Pathol 44(2):206-213, 2020. PMID: 31651523.
- Shen W, Niu N, Lawson B, Qi L, Zhang J, Li T, Zhang H, Liu J. GATA6: a new predictor for prognosis in ovarian cancer. Hum Pathol 86:163-169, 2019. e-Pub 2019. PMID: 30633927.
- Chen PP, Ramalingam P, Alvarado-Cabrero I, Euscher ED, Nagarajan P, Lawson BC, Malpica A. High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases. Am J Surg Pathol. e-Pub 2020. PMID: 32826525.
|Title:||MD Anderson Gynecologic SPORE for Uterine Cancers|